Transversus Abdominis Plane Block and Quadratus Lumborum Block in Pediatric Patients

Pain, Postoperative Clinical Trial

Official title:

Transversus Abdominis Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Pediatric Patients; a Prospective, Randomized, Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04209478
• Other study ID #: BakirkoySadiKonu
• Status: Completed
• Phase: N/A
• Start date: May 1, 2016
• Est. completion date: November 30, 2016

Study information

• Verified date: January 2020
• Source: Bakirkoy Dr. Sadi Konuk Research and Training Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In the pediatric age group, postoperative pain is very important for the children to have a comfortable and problem-free postoperative period.

In the present study, it was aimed to compare the postoperative analgesic efficacy of Transversus abdominis plane (TAP) Block, and quadratus lumborum block (QLB) Type 1 on the pediatric patients

Description:

Patients included in the study were randomly divided into 2 groups. Cases were assessed ultrasonography-guided TAP block (Group B, n=20) or ultrasonography-guided QL Block. Total analgesic amounts in 24 hours and first analgesic requirement times recorded.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: November 30, 2016
• Est. primary completion date: November 30, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 3 Years to 16 Years

Eligibility

Inclusion Criteria:

• The study included 40 cases undergoing lower abdominal surgery aged from 3 to 16 years with American Society of Anesthesiologist I-II level.

Exclusion Criteria:

• Cases with American Society of Anesthesiologist III-IV health level and those with a history of allergy to local anesthetic medications were not included in the study

Related Conditions & MeSH terms

• Pain, Postoperative

Intervention

Drug:
• Tramadol hydrochloride
The Wong-Baker facial pain scale was used to assess pain (1: no pain, 10: worst possible pain). During monitoring patients with pain score =3 had intravenous 1 mg/kg tramadol hydrochloride administered, After 15 minutes following tramadol injection, cases with pain score continuing =3 were to be assessed as insufficient analgesia and had 0.1 mg/kg morphine hydrochloride planned for intravenous administration

Locations

Country	Name	City	State
Turkey	Döndü Genç Moralar	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the analgesic use of the groups in 24 hours	the number of analgesic requirements	how many times in 24 hours

External Links

•   Related Info